In addition, because previous research has found that PDE4DIP is associated with hematological malignancies, we further explored the specific role of PDE4DIP in acute myeloid leukemia (LAML) in depth, providing a new target for the future diagnosis and treatment of various cancers, including LAML. This evidence concerns the gene PDE4DIP and hematologic disorder.